Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
about
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Polycythemia vera treatment algorithm 2018.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
P2860
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@en
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@nl
type
label
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@en
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@nl
prefLabel
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@en
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@nl
P2093
P2860
P356
P1476
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
@en
P2093
Alessandra Carobbio
Alessandro M Vannucchi
Heinz Gisslinger
Juergen Thiele
Tiziano Barbui
P2860
P304
P356
10.1002/AJH.24684
P577
2017-02-14T00:00:00Z